Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens
AbstractCystic fibrosis (CF) is an autosomal recessive genetic disorder which leads to the secretion of a viscous mucus layer on the respiratory epithelium that facilitates colonization by various bacterial pathogens. The problem of drug resistance has been reported for all the species able to colonize the lung of CF patients, so alternative treatments are urgently needed. In this context, a valid approach is to investigate new natural and synthetic molecules for their ability to counteract alternative pathways, such as virulence regulating quorum sensing (QS). In this review we describe the pathogens most commonly associated with CF lung infections: Staphylococcus aureus, Pseudomonas aeruginosa, species of the Burkholderia cepacia complex and the emerging pathogens Stenotrophomonas maltophilia, Haemophilus influenzae and non-tuberculous Mycobacteria. For each bacterium, the QS system(s) and the molecules targeting the different components of this pathway are described. The amount of investigations published in the last five years clearly indicate the interest and the expectations on antivirulence therapy as an alternative to classical antibiotics.
Share & Cite This Article
Scoffone, V.C.; Trespidi, G.; Chiarelli, L.R.; Barbieri, G.; Buroni, S. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens. Int. J. Mol. Sci. 2019, 20, 1838.
Scoffone VC, Trespidi G, Chiarelli LR, Barbieri G, Buroni S. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens. International Journal of Molecular Sciences. 2019; 20(8):1838.Chicago/Turabian Style
Scoffone, Viola Camilla; Trespidi, Gabriele; Chiarelli, Laurent R.; Barbieri, Giulia; Buroni, Silvia. 2019. "Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens." Int. J. Mol. Sci. 20, no. 8: 1838.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.